These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9468230

  • 1. Inflammatory bowel disease and smoking--a review.
    Thomas GA, Rhodes J, Green JT.
    Am J Gastroenterol; 1998 Feb; 93(2):144-9. PubMed ID: 9468230
    [Abstract] [Full Text] [Related]

  • 2. Role of smoking in inflammatory bowel disease: implications for therapy.
    Thomas GA, Rhodes J, Green JT, Richardson C.
    Postgrad Med J; 2000 May; 76(895):273-9. PubMed ID: 10775279
    [Abstract] [Full Text] [Related]

  • 3. Nicotine: does it have a role in the treatment of ulcerative colitis?
    Slyk MP, Frazee LA.
    Am J Ther; 1997 Apr; 4(4):141-8. PubMed ID: 10423604
    [Abstract] [Full Text] [Related]

  • 4. [Tobacco and inflammatory bowel disease].
    Matri S, Karoui S, Filali A.
    Tunis Med; 2000 Dec; 78(12):693-8. PubMed ID: 11155372
    [Abstract] [Full Text] [Related]

  • 5. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH.
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [Abstract] [Full Text] [Related]

  • 6. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
    Guthrie E, Jackson J, Shaffer J, Thompson D, Tomenson B, Creed F.
    Am J Gastroenterol; 2002 Aug; 97(8):1994-9. PubMed ID: 12190166
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN, Triantafillidis JK, Pappa S, Mantas C, Kaltsouda A, Cherakakis P, Alamanos Y, Manousos ON, Mavreas VG.
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P.
    Aliment Pharmacol Ther; 2004 Aug 01; 20(3):303-10. PubMed ID: 15274667
    [Abstract] [Full Text] [Related]

  • 13. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice.
    Cosnes J.
    Best Pract Res Clin Gastroenterol; 2004 Jun 01; 18(3):481-96. PubMed ID: 15157822
    [Abstract] [Full Text] [Related]

  • 14. [Pathogenetic models ulcerative colitis and Crohn disease].
    Feller AC, Löhler J, Reimann J, Merz H.
    Verh Dtsch Ges Pathol; 1996 Jun 01; 80():104-8. PubMed ID: 9064992
    [Abstract] [Full Text] [Related]

  • 15. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T, Voigt E, Gretzer B, Brasch F, May B.
    Hepatogastroenterology; 1999 Jun 01; 46(26):920-3. PubMed ID: 10370639
    [Abstract] [Full Text] [Related]

  • 16. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.
    J Pediatr Gastroenterol Nutr; 2007 May 01; 44(5):653-74. PubMed ID: 17460505
    [Abstract] [Full Text] [Related]

  • 17. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ, Mieremet-Ooms MA, van der Zon AM, van Duijn W, van Hogezand RA, Sier CF, Hommes DW, Lamers CB, Verspaget HW.
    Dig Liver Dis; 2007 Aug 01; 39(8):733-9. PubMed ID: 17602907
    [Abstract] [Full Text] [Related]

  • 18. Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines?
    Zijlstra FJ.
    Mediators Inflamm; 1998 Aug 01; 7(3):153-5. PubMed ID: 9705601
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M, Zerbini MC, Barbieri D.
    Arq Gastroenterol; 1998 Aug 01; 35(3):223-36. PubMed ID: 10029869
    [Abstract] [Full Text] [Related]

  • 20. Commonalities in the time trends of Crohn's disease and ulcerative colitis.
    Delcò F, Sonnenberg A.
    Am J Gastroenterol; 1999 Aug 01; 94(8):2171-6. PubMed ID: 10445545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.